-
-
-
-
-
-
-
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis
-
-
-
-
-
-
-
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $87 at Leerink Partners
-
-
-
-
-
-
-
Incyte (INCY) Misses Q1 EPS by 18c ; Offers Guidance
-
-
-
-
-
-
-
Incyte (INCY) Highlights Growth Opportunities and Provides Business Updates
-
-
-
-
-
-
-
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
-
1,200,281 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

